Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-22

Clinical Trial Update: Fluphenazine Decanoate for Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 trial of fluphenazine decanoate for psoriasis was terminated, with results posted in December 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine decanoate (Fluphenazine decanoate)

Snippet

Sponsor: Tufts Medical Center | Conditions: Psoriasis | Phase 2 | Status: TERMINATED | Results posted: 2010-12-22